Vitamins

What Causes Low Vitamin D in Women?

Vitamin D deficiency affects an estimated 41% of U.S. adults, but women face a uniquely layered set of risk factors — from hormonal shifts and adipose sequestration to thyroid dysfunction and medication interactions. Left unaddressed, low 25(OH)D quietly undermines bone density, immune function, mood, and fertility over years before symptoms become undeniable.

Jared Murray ·Co-Founder & Head of Health Research, Ones · ·10 min read
vitamin D deficiencyvitamin D3 for womenvitamin D and menopausevitamin K2 MK-7low vitamin D causes
What Causes Low Vitamin D in Women?

What Causes Low Vitamin D in Women?

Low vitamin D in women is primarily caused by insufficient sun exposure, combined with factors like darker skin tone, obesity, malabsorption conditions, and age-related changes in skin synthesis. The main caveat is that many women are mildly insufficient rather than severely deficient, and symptoms can be vague. The exception is women with fat-malabsorption disorders or those taking certain medications — they can develop frank deficiency even with reasonable sun and dietary intake.

---

Why Vitamin D Deficiency Is So Widespread in Women

Vitamin D is technically a hormone precursor, not a classic vitamin. Your skin synthesizes it from UVB radiation, your liver converts it to 25-hydroxyvitamin D (25(OH)D), and your kidneys then activate it into its biologically potent form, calcitriol. Any disruption along that pathway — and there are many — results in low serum 25(OH)D.

Data from the National Health and Nutrition Examination Survey (NHANES) found that approximately 41.6% of U.S. adults had serum 25(OH)D below 20 ng/mL, with the highest deficiency rates seen in Black and Hispanic women (Forrest & Stuhldreher, Nutrition Research 2011; PMID: 21310306). Women also face a unique set of compounding factors: pregnancy and breastfeeding draw heavily on vitamin D stores, menopause reduces conversion efficiency, and estrogen fluctuations can influence vitamin D receptor (VDR) gene expression.

What makes vitamin D unusual among micronutrients is the breadth of its receptor distribution. VDRs are present in more than 36 tissue types, including breast tissue, ovarian cells, the thyroid, and the brain. This means deficiency doesn't produce one clear symptom — it produces dozens of overlapping, low-grade ones. Understanding the root causes — not just taking a random supplement dose — is the most reliable path to restoring status.

---

The Most Common Causes of Low Vitamin D in Women

1. Inadequate Sun Exposure

The single largest driver of low vitamin D is not getting enough UVB sunlight on bare skin. Office-based work, northern latitudes (above 37°N), consistent sunscreen use, and covering clothing all limit synthesis dramatically. A pale-skinned woman in Boston in January produces essentially zero vitamin D from sun exposure, while a woman in Miami can synthesize adequate amounts year-round — with important caveats around time of day and cloud cover.

The mechanism matters here: UVB photons convert 7-dehydrocholesterol in the epidermis to previtamin D3, which then isomerizes thermally to vitamin D3 over several hours. Sunscreen with SPF 30 reduces this conversion by roughly 95%, and glass blocks UVB entirely — meaning indoor light exposure near a window contributes nothing to vitamin D synthesis.

2. Skin Pigmentation

Melanin in darker skin acts as a natural UVB filter. Women with deeper skin tones require three to five times longer sun exposure to produce the same amount of vitamin D as women with fair skin. This is why deficiency rates are disproportionately higher in Black and Hispanic women in the United States (PMID: 21310306). Critically, this isn't a dietary problem or a behavior problem — it's a photobiological reality that requires higher supplemental intake to compensate.

3. Adiposity and Fat Sequestration

Vitamin D is fat-soluble. In women with higher body fat percentages, vitamin D gets sequestered in adipose tissue, reducing its bioavailability in circulation. A meta-analysis found an inverse relationship between BMI and serum 25(OH)D, with obese individuals often needing two to three times the supplemental dose to reach the same blood level as lean individuals (Pereira-Santos et al., European Journal of Nutrition 2015; PMID: 25308766). The adipose reservoir is not entirely inert — it can release stored vitamin D slowly — but during periods of active depletion (e.g., pregnancy, illness), that sequestration becomes a clinical problem rather than a buffer.

4. Age and Menopause — Vitamin D3 for Women Over 40

Skin thickness and the concentration of 7-dehydrocholesterol — the vitamin D precursor in skin — both decline with age. Women over 50 produce approximately 25% less vitamin D per unit of UVB exposure than younger women. Additionally, the decline in estrogen after menopause reduces intestinal calcium absorption and may affect VDR sensitivity, compounding vitamin D's functional impact on bone turnover and immune signaling.

A randomized trial by Gallagher et al. in the Journal of Clinical Endocrinology & Metabolism (2012; PMID: 22442280) found that postmenopausal women required 800–2,000 IU of vitamin D3 daily to reliably maintain 25(OH)D above 20 ng/mL, with the higher end of that range needed in women with higher BMI or lower baseline sun exposure. This is why vitamin D3 for women over 40 becomes a clinical priority rather than optional optimization, especially when combined with declining magnesium intake, which is required as a cofactor for vitamin D conversion in both the liver and kidney.

5. Malabsorption and Gut Conditions

Because vitamin D is fat-soluble, any condition that impairs fat absorption will reduce dietary vitamin D uptake. Celiac disease, Crohn's disease, short bowel syndrome, and bariatric surgery all create significant malabsorption risk. Even subclinical gut inflammation — common in women with low ferritin or low iron — can modestly impair nutrient absorption, including vitamin D.

In women post-bariatric surgery, 25(OH)D levels often remain deficient despite supplementation at standard doses, because the proximal small intestine — where vitamin D is primarily absorbed — has been bypassed or reduced. These women frequently require 3,000–6,000 IU/day under medical supervision to reach sufficiency.

6. Thyroid and Hormonal Dysfunction

Hypothyroidism slows liver conversion of vitamin D to its storage form. Women with low thyroid function frequently present with suboptimal 25(OH)D levels even when dietary intake looks adequate. The relationship runs bidirectionally: vitamin D deficiency also impairs thyroid hormone synthesis and may worsen autoimmune thyroid disease (Mazokopakis & Kotsiris, Hellenic Journal of Nuclear Medicine 2014). Women with low TSH — including those with subclinical hyperthyroidism — can paradoxically also run low in vitamin D due to accelerated bone turnover and urinary calcium wasting; you can read more about these patterns in our guide to what causes low TSH in women.

Hormonal links extend beyond the thyroid. Low progesterone states — common in perimenopause and certain luteal phase defects — are associated with reduced VDR expression in uterine and immune tissue, which may amplify the functional consequences of borderline 25(OH)D levels even when serum numbers look acceptable. For more context on hormonal interplay, see what causes low progesterone in women.

7. Medications

Several common medications accelerate vitamin D catabolism or interfere with absorption:

  • Corticosteroids reduce intestinal calcium absorption and increase vitamin D breakdown via induction of CYP24A1, the enzyme responsible for vitamin D degradation.
  • Anticonvulsants (phenytoin, carbamazepine) induce liver enzymes that degrade 25(OH)D, often dramatically.
  • Cholestyramine and orlistat reduce fat-soluble vitamin absorption by binding bile acids or blocking fat digestion, respectively.
  • Proton pump inhibitors (PPIs) can indirectly lower vitamin D through impaired calcium and magnesium absorption, since magnesium is required for vitamin D activation.

8. Dietary Insufficiency

Few foods naturally contain meaningful vitamin D: fatty fish (salmon, mackerel), egg yolks, and UV-exposed mushrooms are the primary sources. Women following plant-based diets or those avoiding seafood often fall short of even the modest recommended dietary allowance (RDA) of 600–800 IU/day — a figure many researchers argue is too low to maintain optimal serum levels anyway (Heaney et al., Journal of Clinical Endocrinology & Metabolism 2015; PMID: 25333201). The Endocrine Society's clinical practice guideline suggests that most adults need at least 1,500–2,000 IU/day from all sources combined to maintain 25(OH)D consistently above 30 ng/mL.

---

Symptoms of Low Vitamin D in Women

Vitamin D deficiency rarely announces itself clearly. The symptoms overlap with a dozen other conditions, which is one reason it goes undetected for years.

Symptom CategoryCommon Presentations
MusculoskeletalBone pain, muscle weakness, increased fracture risk
ImmuneFrequent infections, slow wound healing
Mood & CognitiveLow mood, seasonal depression, brain fog
FatiguePersistent tiredness unrelated to sleep
HormonalIrregular cycles, worsened PMS, impaired fertility
CardiovascularElevated blood pressure, arterial stiffness

A 2020 systematic review found that vitamin D deficiency was associated with a 1.5-fold increased risk of depression symptoms, though the direction of causality remains under investigation (Shaffer et al., Journal of Affective Disorders 2020; PMID: 32777692). Musculoskeletal symptoms — particularly diffuse bone pain and proximal muscle weakness — are more specific for true deficiency (25(OH)D below 10 ng/mL) and often resolve within 6–12 weeks of aggressive repletion.

One underappreciated symptom pattern is recurrent respiratory illness. Vitamin D upregulates cathelicidin and defensins, two antimicrobial peptides that form part of the innate immune response in mucous membranes. Women with 25(OH)D below 20 ng/mL have roughly double the risk of acute respiratory tract infections compared to those above 30 ng/mL (Martineau et al., BMJ 2017; PMID: 28202713).

---

Vitamin D for Women: Testing, Targets, and Repletion Protocol

Testing is straightforward: a serum 25-hydroxyvitamin D test (the correct test — not 1,25-dihydroxyvitamin D, which is often normal even in deficiency) gives an accurate picture of stores. Standard interpretation:

Serum 25(OH)D LevelClassification
Below 12 ng/mLSevere deficiency
12–19 ng/mLDeficiency
20–29 ng/mLInsufficiency
30–50 ng/mLSufficient (most guidelines)
50–80 ng/mLOptimal (Endocrine Society target for at-risk groups)
Above 100 ng/mLPotential toxicity zone

For repletion from deficiency, a common evidence-based protocol uses 4,000–6,000 IU/day of vitamin D3 for 8–12 weeks, followed by maintenance dosing of 1,500–2,000 IU/day — retested at 3 months. The D3 form (cholecalciferol) is significantly more effective than D2 (ergocalciferol) at raising and sustaining 25(OH)D levels (Tripkovic et al., American Journal of Clinical Nutrition 2012; PMID: 22552031). Taking vitamin D with the largest fat-containing meal of the day increases absorption by approximately 50% compared to taking it fasted.

The Role of Vitamin K in Vitamin D Supplementation

Higher-dose vitamin D3 supplementation increases intestinal calcium absorption, which raises a question about where that calcium ends up. Vitamin K2 (specifically the MK-7 form) activates matrix GLA protein (MGP) and osteocalcin — two proteins that direct calcium into bone and away from arterial walls. Without adequate K2, supplementing high-dose vitamin D can theoretically accelerate vascular calcification in susceptible individuals. This is not a reason to avoid vitamin D supplementation; it is a reason to co-administer K2, particularly in women over 40 with cardiovascular risk factors.

Note that vitamin K1 (phylloquinone), found in leafy greens, primarily supports hepatic coagulation factor synthesis and has weaker effects on MGP activation than K2. Vitamin K1 for women is not an effective substitute for K2 when the goal is directing calcium traffic during vitamin D repletion — the two forms have distinct tissue distributions and biological roles.

---

What This Means for Your Formula

At Ones, every supplement formula is built from a person's actual lab data — including serum 25(OH)D — not from generic population recommendations. When vitamin D insufficiency or deficiency is identified, Ones formulas incorporate Vitamin D3 + K2 (MK-7), pairing cholecalciferol at clinically meaningful doses with the MK-7 form of K2 to support calcium partitioning and bone mineralization in tandem.

Because magnesium is an essential cofactor for both hepatic and renal vitamin D conversion, women with suboptimal 25(OH)D alongside low dietary magnesium intake receive Magnesium Glycinate as part of their formula — supporting the enzymatic steps that turn supplemental D3 into bioavailable calcitriol. Research by Deng et al. (American Journal of Clinical Nutrition 2024; PMID: 38309628) confirmed that magnesium status significantly modified the association between vitamin D intake and 25(OH)D levels, underscoring that D3 supplementation without adequate magnesium has limited effect in some women.

For women whose low vitamin D presentation includes immune vulnerability or recurrent illness, Ones may also incorporate its Immune-C System Blend, which addresses the overlapping immune pathways that vitamin D and vitamin C co-regulate — particularly mucosal defense and T-cell activation. The goal is never to add ingredients in isolation but to address the full picture that the biomarker data reveals.

---

Key Takeaways

  • Low vitamin D in women is overwhelmingly driven by inadequate UVB exposure, compounded by skin pigmentation, body fat, age, gut function, thyroid status, and certain medications.
  • Serum 25(OH)D is the correct test; a result below 20 ng/mL indicates deficiency requiring active repletion, not just maintenance dosing.
  • Vitamin D3 is meaningfully superior to D2 for raising blood levels and should always be taken with a fat-containing meal for best absorption.
  • Women over 40 face amplified risk due to reduced skin synthesis capacity and post-menopausal shifts in calcium metabolism, making higher supplemental doses necessary to maintain sufficiency.
  • Vitamin K2 (MK-7) should accompany higher-dose vitamin D3 to direct absorbed calcium into bone rather than soft tissue; vitamin K1 does not perform the same function.
  • Magnesium is a cofactor for vitamin D activation — women deficient in both will not respond normally to D3 supplementation alone, and both must be addressed together.

Written by Jared Murray, Co-Founder & Head of Health Research, Ones.

Jared is the co-founder and head of health research at Ones, with 25 years applying nutrition science, biomarker interpretation, and clinical supplementation research to individual health programs. He leads the editorial process for the Ones Health Library, where lab data, wearable biometrics, and peer-reviewed clinical research are translated into evidence-based, personalized supplement guidance.

Disclosure: Ones formulates and sells personalized supplements that may include ingredients discussed in this article. We have a financial interest in the products mentioned. Recommendations are based on published research and our editorial standards, not sales targets.

This article is educational content, not medical advice. Consult a healthcare provider before changing your supplement regimen.

Further reading

Related reading